• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

红细胞输血相关风险:对重症监护实践的启示。

The Risks Associated with Red Blood Cell Transfusion: Implications for Critical Care Practice.

作者信息

Sutton Douglas H, Raines Deborah A

机构信息

College of Health and Human Services, Northern Arizona University, 2065 West Dolores Lane, Flagstaff, AZ 86005, USA.

School of Nursing, University at Buffalo, 3435 Main Street, Buffalo, NY 14214-3079, USA.

出版信息

Crit Care Nurs Clin North Am. 2017 Sep;29(3):305-314. doi: 10.1016/j.cnc.2017.04.012. Epub 2017 Jun 21.

DOI:10.1016/j.cnc.2017.04.012
PMID:28778290
Abstract

This systematic literature review informs the clinician caring for the critically ill patient of the risks associated with red blood cell (RBC) transfusion. Data were extracted from publications between 2008 and 2016 and were reviewed to determine their usefulness in providing evidence associated with the risk of receiving an RBC transfusion. They reveal that this intervention may exacerbate certain clinical conditions and increase mortality and morbidity rates. Further scientific study is needed to better inform clinical practitioners about the inherent risks and benefits associated with the common clinical intervention of RBC transfusion in the critically ill patient.

摘要

这项系统性文献综述旨在让负责重症患者护理的临床医生了解红细胞(RBC)输血相关风险。数据取自2008年至2016年间的出版物,并进行了审查,以确定其在提供与接受RBC输血风险相关证据方面的有用性。结果显示,这种干预可能会加剧某些临床状况,并增加死亡率和发病率。需要进一步的科学研究,以便更好地让临床医生了解重症患者中RBC输血这一常见临床干预措施所固有的风险和益处。

相似文献

1
The Risks Associated with Red Blood Cell Transfusion: Implications for Critical Care Practice.红细胞输血相关风险:对重症监护实践的启示。
Crit Care Nurs Clin North Am. 2017 Sep;29(3):305-314. doi: 10.1016/j.cnc.2017.04.012. Epub 2017 Jun 21.
2
Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell support.对于接受强化化疗或放疗或两者联合治疗、有或没有造血干细胞支持的血液系统恶性肿瘤患者,采用限制性与宽松性红细胞输血策略的比较。
Cochrane Database Syst Rev. 2017 Jan 27;1(1):CD011305. doi: 10.1002/14651858.CD011305.pub2.
3
Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature.红细胞输注对危重症患者的疗效:文献系统综述
Crit Care Med. 2008 Sep;36(9):2667-74. doi: 10.1097/CCM.0b013e3181844677.
4
Transfusion thresholds for guiding red blood cell transfusion.输血阈值指导红细胞输血。
Cochrane Database Syst Rev. 2021 Dec 21;12(12):CD002042. doi: 10.1002/14651858.CD002042.pub5.
5
Transfusion guidelines in adult spine surgery: a systematic review and critical summary of currently available evidence.成人脊柱手术中的输血指南:对当前可用证据的系统评价与批判性总结
Spine J. 2022 Feb;22(2):238-248. doi: 10.1016/j.spinee.2021.07.018. Epub 2021 Jul 31.
6
Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.输血预防镰状细胞病患者的原发性和继发性中风
Cochrane Database Syst Rev. 2017 Jan 17;1(1):CD003146. doi: 10.1002/14651858.CD003146.pub3.
7
The Effects of red Blood Cell Transfusion on Tissue Oxygenation and the Microcirculation in the Intensive Care Unit: A Systematic Review.《红细胞输血对重症监护病房组织氧合和微循环的影响:系统评价》。
Transfus Med Rev. 2017 Oct;31(4):205-222. doi: 10.1016/j.tmrv.2017.07.003. Epub 2017 Jul 21.
8
Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.早期使用促红细胞生成素预防早产和/或低出生体重儿的红细胞输血
Cochrane Database Syst Rev. 2006 Jul 19(3):CD004863. doi: 10.1002/14651858.CD004863.pub2.
9
Long-Term Transfusion Independence with Luspatercept Versus Epoetin Alfa in Erythropoiesis-Stimulating Agent-Naive, Lower-Risk Myelodysplastic Syndromes in the COMMANDS Trial.在COMMANDS试验中,对于未使用过促红细胞生成素、低风险的骨髓增生异常综合征患者,卢司帕西普与阿法依泊汀实现长期输血独立的比较
Adv Ther. 2025 May 16. doi: 10.1007/s12325-025-03208-5.
10
Prothrombin complex concentrate in cardiac surgery for the treatment of coagulopathic bleeding.心脏手术中使用凝血酶原复合物浓缩物治疗凝血功能障碍性出血。
Cochrane Database Syst Rev. 2022 Nov 21;11(11):CD013551. doi: 10.1002/14651858.CD013551.pub2.

引用本文的文献

1
Transfusion Thresholds and Neurological Functional Outcome After Acute Brain Injury: An Updated Systematic Review and Meta-Analysis of Randomized Clinical Trials.急性脑损伤后输血阈值与神经功能转归:随机临床试验的最新系统评价与Meta分析
J Clin Med. 2025 May 16;14(10):3487. doi: 10.3390/jcm14103487.
2
Cost Reduction in Blood Transfusions After Implementation of Decision Protocol Based on Hemoglobin and Anemia Symptoms: A Pre-Post Analysis.基于血红蛋白和贫血症状的决策方案实施后输血成本的降低:一项前后分析
Med Sci Monit. 2024 Dec 4;30:e945854. doi: 10.12659/MSM.945854.
3
Appropriateness of Allogeneic Red Blood Cell Transfusions in Non-Bleeding Patients in a Large Teaching Hospital: A Retrospective Study.
大型教学医院非出血患者同种异体红细胞输注的适宜性:一项回顾性研究
J Clin Med. 2023 Feb 6;12(4):1293. doi: 10.3390/jcm12041293.
4
Long length of stay in the ICU associates with a high erythrocyte transfusion rate in critically ill patients.重症监护病房(ICU)住院时间长与危重症患者红细胞输注率高相关。
J Int Med Res. 2019 May;47(5):1948-1957. doi: 10.1177/0300060519832458. Epub 2019 Mar 12.